No Data
Inari Medical Announces Reimbursement Approval for ClotTriever Thrombectomy System in Japan and New Distribution Partnership With Medikit Co., Ltd.
Japanese stock buybacks this week (11/11~11/15)
――――11/11――――$KYB(7242.JP)$ will buy back up to 4.6 million shares, 18.4% of its outstanding shares (excluding its own shares), for an amount of JPY¥ 20 billion.$Persol Holdings(2181.JP)$ will
Medikit: Half Year Report - Term 42 (2024/04/01 - 2025/03/31)
Nisshin Food Holdings and others announced a share buyback on November 11th.
The stocks that announced the establishment of a share buyback framework on November 11th (Monday) are as follows. <7242> KYB 4.6 million shares (18.4%) 20 billion yen (24/11/12-24/11/12) <7749> Medikit 0.25 million shares (1.7%) 0.7 billion 11.75 million yen (24/11/12-25/2/28) <6180> GMO Media 0.02 million shares (1.1%) 0.1 billion yen (24/11/12-25/3/31) <8331> Chiba Silver 12 million shares (1.7%) 10 billion yen (24/11/
Recruit Holdings, 2Q operating profit increased by 13.4% to 269.7 billion yen
Recruit root inc <6098> announced its fiscal second quarter results for March 2025, with sales revenue increasing by 5.4% year-on-year to 1 trillion 798.7 billion 5 million yen, and operating profit increasing by 13.4% year-on-year to 269.7 billion 8 million yen. All HR technology business, matching & solution business, and temporary staffing business saw an increase in revenue. The consensus (approximately 255 billion yen) was exceeded. The operating profit for the March 2025 period was revised upwards from 390 billion yen to 442.7 billion yen. Consensus.
Medikit: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)